Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 29, 2020

SELL
$8.73 - $12.95 $2.86 Million - $4.25 Million
-327,860 Closed
0 $0
Q3 2019

Oct 31, 2019

BUY
$14.16 - $25.34 $2.8 Million - $5.01 Million
197,840 Added 152.16%
327,860 $4.81 Million
Q2 2019

Jul 31, 2019

BUY
$27.0 - $30.25 $3.51 Million - $3.93 Million
130,020 New
130,020 $3.53 Million

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $225M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Emerald Advisers, LLC Portfolio

Follow Emerald Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.